N-(aroyl)glycine hydroxamic acid derivatives and related compounds
US6384236B1 · kind B1 · utility
3Cited by
11References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 25, 2001 |
| Grant date | May 7, 2002 |
| Priority date | — |
| Expiry date | Jan 25, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, AA and Y are as defined herein, inhibit phosphodiesterase type IV or inhibit the production of tumor necrosis factor, and therefore are useful in the treatment of certain conditions and diseases including asthma, arthritis, and sepsis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.